Patents by Inventor Uwe R. Müller

Uwe R. Müller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKER DETECTION PROCESS AND ASSAY OF NEUROLOGICAL CONDITION
    Publication number: 20210011028
    Abstract: The subject invention provides a robust, quantitative, and reproducible process and assay for diagnosis of a neurological condition in a subject. The invention provides measurement of two or more biomarkers in a biological fluid such as CSF or serum resulting in a synergistic mechanism for determining the extent of neurological damage in a subject with an abnormal neurological condition and for discerning subtypes thereof or tissue types subjected to damage.
    Type: Application
    Filed: June 2, 2020
    Publication date: January 14, 2021
    Applicant: Banyan Biomarkers, Inc.
    Inventors: Kevin Ka-Wang WANG, Ronald L. HAYES, Uwe R. MUELLER, Zhiqun ZHANG
  • BIOMARKER DETECTION PROCESS AND ASSAY OF NEUROLOGICAL CONDITION
    Publication number: 20180031577
    Abstract: The subject invention provides a robust, quantitative, and reproducible process and assay for diagnosis of a neurological condition in a subject. The invention provides measurement of two or more biomarkers in a biological fluid such as CSF or serum resulting in a synergistic mechanism for determining the extent of neurological damage in a subject with an abnormal neurological condition and for discerning subtypes thereof or tissue types subjected to damage.
    Type: Application
    Filed: September 19, 2017
    Publication date: February 1, 2018
    Applicant: BANYAN BIOMARKERS, INC.
    Inventors: Kevin Ka-wang WANG, Ronald L. HAYES, Uwe R. MUELLER, Zhiqun ZHANG
  • BIOMARKER DETECTION PROCESS AND ASSAY OF NEUROLOGICAL CONDITION
    Publication number: 20110143375
    Abstract: The subject invention provides a robust, quantitative, and reproducible process and assay for diagnosis of a neurological condition in a subject. The invention provides measurement of two or more biomarkers in a biological fluid such as CSF or serum resulting in a synergistic mechanism for determining the extent of neurological damage in a subject with an abnormal neurological condition and for discerning subtypes thereof or tissue types subjected to damage.
    Type: Application
    Filed: August 11, 2009
    Publication date: June 16, 2011
    Applicant: Banyan Blomakers, Inc.
    Inventors: Kevin Ka-wang Wang, Ronald L. Hayes, Uwe R. Mueller, Zhiqun Zhang
  • Method for genotyping DNA tandem repeat sequences
    Publication number: 20100196893
    Abstract: The present invention provides methods for determining the number of tandem repeat units in a region of double stranded DNA based on the use of RecA-like recombinase protein and oligonucleotide ligation. The methods of the present invention provide RecA coated, specific DNA oligonucleotide probes (RecA filaments) for homology searching in duplex DNA where the location of homologous sequences results in the formation of D-loop structures containing a duplex region comprising the oligonucleotide probe and one strand of the target DNA.
    Type: Application
    Filed: October 15, 2009
    Publication date: August 5, 2010
    Applicant: Gene Check, Inc.
    Inventors: Uwe R. Müller, Robert E. Wagner, JR.